Product Information
AUROVELA FE 1-20 TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1287 per EA under NDC 65862094088. Its NADAC has been published 379 times since Jul 3, 2019.
FDA first approved this application on Jun 16, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
AUROVELA FE 1-20 TABLET
Norethindrone Acetate and Ethinyl Estradiol and Ferrous FumarateManufacturer
Aurobindo Pharma LimitedNDC
65862094088
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA207505FDA Approved
6/16/2017
TE Code
AB
On Market Since
6/16/2017
Price Statistics
The NADAC for AUROVELA FE 1-20 TABLET has been published 379 times since Jul 3, 2019, and over the history we have for it it has declined 58.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1287 per EA |
|---|---|
| All-time high | $0.3795 (Feb 12, 2020) |
| All-time low | $0.1176 (May 22, 2024) |
| 52-week high | $0.1517 |
| 52-week low | $0.1277 |
| Median price | $0.1648 |
| Average price | $0.2019 |
| Largest weekly change | +35.6% (Jun 17, 2020) |
| Weeks tracked | 379 |
| Tracking since | Jul 3, 2019 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AUROVELA FE 1-20 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AUROVELA FE 1-20 TABLET, manufactured by Aurobindo Pharma Limited, is $0.1287 per EA (NDC 65862094088), effective Sep 30, 2026.
How has the price of AUROVELA FE 1-20 TABLET changed over time?
Over the history we have for it, the NADAC for AUROVELA FE 1-20 TABLET has declined 58.2%. It has been tracked across 379 weekly CMS publications since Jul 3, 2019.
What are the highest and lowest recorded NADAC prices for AUROVELA FE 1-20 TABLET?
Since Jul 3, 2019, the NADAC for AUROVELA FE 1-20 TABLET has ranged from a low of $0.1176 (May 22, 2024) to a high of $0.3795 (Feb 12, 2020), with a median of $0.1648 per EA.
Are there cheaper alternatives to AUROVELA FE 1-20 TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AUROVELA FE 1-20 TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures AUROVELA FE 1-20 TABLET?
AUROVELA FE 1-20 TABLET (NDC 65862094088) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.